The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection has been updated! For a complete preview of key updates to the guidelines, please see What's New in the Guidelines.
Please send your comments with the subject line “Comments on Pediatric Antiretroviral Treatment Guidelines” to ContactUs@aidsinfo.nih.gov by February 26, 2014.
(Last updated:11/1/2012; last reviewed:11/1/2012)
Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus
Lipodystrophy, Lipohypertrophy, Lipoatrophy
Osteopenia and Osteoporosis
Peripheral Nervous System Toxicity
Rash and Hypersensitivity Reactions